CSIMarket
 
Summit Therapeutics Plc  (SMMT)
Other Ticker:  
 
 
Price: $1.2700 $-0.02 -1.550%
Day's High: $1.3 Week Perf: -3.05 %
Day's Low: $ 1.21 30 Day Perf: -3.05 %
Volume (M): 44 52 Wk High: $ 2.50
Volume (M$): $ 56 52 Wk Avg: $1.65
Open: $1.30 52 Wk Low: $1.10



 Market Capitalization (Millions $) 53
 Shares Outstanding (Millions) 42
 Employees -
 Revenues (TTM) (Millions $) 43
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) 47
 Capital Exp. (TTM) (Millions $) 0

Summit Therapeutics Plc


 

Summit Therapeutics Plc's Segments
 
 
  Company Estimates  
  Revenue Outlook
Summit Therapeutics Plc does not provide revenue guidance.

Earnings Outlook
Summit Therapeutics Plc does not provide earnings estimates.

 
Geographic Revenue Dispersion

Crypto Co

Crypto Co announced second quarter operating shortfall of $-0.315116 millions

In the second quarter Crypto Co decreased loss of $-0.01 per share compare to $-0.34 a year ago and improved from $-0.02 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Biocorrx Inc.

Biocorrx Inc announced second quarter operating shortfall of $-1.599904 millions

In the second quarter Biocorrx Inc losses widen of $-0.67 per share compare to $0.00 a year ago and from $-0.67 per share from the previous quarter.

Sales faded by -33.14 % to $0.07 millions from $0.10 millions in the same quarter a year ago and sequentially Sales increased by 1.08 % from $0.07 millions.

Premier Biomedical Inc

Logged a Loss, Topline Tumbles

In the second quarter Premier Biomedical Inc lost money of $-0.02 per share compare to $-0.03 a year ago and eps fell from $0.01 per share from the previous quarter.

Sales fell sharply to $0.00 millions from $0.01 millions in the same quarter a year ago and sequentially from $0.01 millions.

Nebula Acquisition Corp

Significant EPS Decline, Revenues Unchanged

In the second quarter Nebula Acquisition Corp income dropped by -33.33 % of $0.02 per share compare to $0.03 a year ago and profit plummeted by -50 % from $0.04 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Luckwel Pharmaceuticals Inc.

Sales and Earnings Unchanged

In the first quarter Luckwel Pharmaceuticals Inc reached break-even of $-0.00 per share compare to $-0.01 a year ago and from $-0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ARUU's Profile

Stock Price

ARUU's Financials

Business Description

Fundamentals

Charts & Quotes

ARUU's News

Suppliers

ARUU's Competitors

Customers & Markets

Economic Indicators

ARUU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071